PhoenixBio: Interim report
PhoenixBio: Extraordinary Report
PhoenixBio: Confirmatory letter.
PhoenixBio: Financial Report - Term 23 (2023/04/01 - 2024/03/31)
PHOENIXBIO: Notice regarding financial results of unlisted parent companies, etc.
PHOENIXBIO: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (consolidated)
Phoenix Bio: Confirmation Letter
Phoenix Bio: Quarterly Report - 23rd Quarter (2023/10/01 to 2023/12/31)
PhoenixBio: Summary of Financial Results for the 3rd Quarter Ending March 31, 2024 [Japanese GAAP] (Consolidated)
PhoenixBio: Extraordinary Report
PhoenixBio: Confirmation letter
PhoenixBio: Quarterly Report - 23rd Second Quarter (2023/07/01 - 2023/09/30)
PhoenixBio: Notice regarding differences between consolidated earnings forecasts for the second quarter of the fiscal year ending March 31, 2024 and actual values, and revisions to the full-year consolidated earnings forecast
PhoenixBio: Summary of Financial Results for the 2nd Quarter Ending March 2024 [Japanese GAAP] (Consolidated)
PhoenixBio: Confirmation letter
PhoenixBio: Quarterly Report - First Quarter 23 (2023/04/01 - 2023/06/30)
PhoenixBio: Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
PhoenixBio: Extraordinary Report
PhoenixBio: Confirmation letter
PhoenixBio: Securities Report - 22nd Period (2022/04/01 - 2023/03/31)
No Data